- Report
- May 2026
- 373 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 268 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 292 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 274 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 391 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 265 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- September 2025
- 148 Pages
Global
From €3534EUR$3,999USD£3,061GBP
- Report
- June 2025
- 200 Pages
Global
From €2209EUR$2,500USD£1,913GBP
- Report
- January 2026
- 160 Pages
Global
From €4414EUR$4,995USD£3,823GBP
- Report
- July 2025
- 226 Pages
Global
From €3932EUR$4,450USD£3,406GBP
- Report
- January 2026
- 160 Pages
Global
From €2967EUR$3,358USD£2,570GBP
€3491EUR$3,950USD£3,023GBP
- Report
- October 2025
- 160 Pages
Global
From €2967EUR$3,358USD£2,570GBP
€3491EUR$3,950USD£3,023GBP
- Report
- October 2025
- 160 Pages
Global
From €2967EUR$3,358USD£2,570GBP
€3491EUR$3,950USD£3,023GBP
- Report
- July 2025
- 86 Pages
Global
From €3500EUR$4,243USD£3,137GBP
- Report
- September 2025
- 135 Pages
Global
From €4286EUR$4,850USD£3,712GBP
- Report
- July 2025
- 210 Pages
Global
From €4286EUR$4,850USD£3,712GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3419EUR$3,869USD£2,961GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3419EUR$3,869USD£2,961GBP
- Report
- December 2025
- 150 Pages
United States
From €4286EUR$4,850USD£3,712GBP
- Report
- October 2025
- 99 Pages
Middle East
From €4286EUR$4,850USD£3,712GBP

Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more